Neutralizing antibodies against the activin receptor-like kinase 7 (ALK7), induced a significant loss of adipose mass and improved insulin resistance in genetic and diet-induced obesity mouse models (Zhao et al. 2023). This evidence concerns the gene ACVR1C and obesity disorder.